Literature DB >> 2703536

Lipolytic surface remnants of triglyceride-rich lipoproteins are cytotoxic to macrophages but not in the presence of high density lipoprotein. A possible mechanism of atherogenesis?

B H Chung1, J P Segrest, K Smith, F M Griffin, C G Brouillette.   

Abstract

Hypertriglyceridemic (HTG) serum, lipolyzed in vitro by purified bovine milk lipoprotein lipase, was found to be cytotoxic to cultured macrophages. Surviving macrophages contained numerous lipid inclusions similar to those found in foam cells. Individual lipoprotein fractions isolated from the lipolyzed HTG serum, including HDL, were also cytotoxic. Lipolysis of isolated lipoprotein fractions (either HTG or normal) allowed localization of cytotoxicity to postlipolysis remnant VLDL and chylomicron particles. The presence of a critical concentration of HDL in either the lipolysis mixture or the culture dishes inhibited the cytotoxicity. Below this critical concentration HDL itself became cytotoxic, producing lipid inclusions in surviving macrophages. The lipid fraction of the cytotoxic remnants contained the cytotoxic factor(s); neither FFA nor lysolecithin alone could account for this cytotoxicity. Postprandial lipemic sera from subjects with a brisk chylomicron response, when lipolyzed in vitro, were cytotoxic to cultured macrophages; neither fasted sera from these subjects, nor postprandial sera from normolipidemic subjects with a normal chylomicron response, were cytotoxic. Postheparin (in vivo lipolyzed) serum and its isolated lipoprotein fractions obtained 30 min after heparin injection in subjects with HTG were shown to be cytotoxic to macrophages; by 60 min most of the cytotoxicity had disappeared. The postprandial and postheparin observations support an in vivo significance for remnant-associated cytotoxicity. We hypothesize that cytotoxic remnants of lipolyzed VLDL and chylomicrons may be one of the major atherogenic lipoproteins. Further, we suggest that inhibition of the cytotoxicity of these remnants may be one important way that HDL prevents atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2703536      PMCID: PMC303830          DOI: 10.1172/JCI114024

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  A simple method of obtaining monocytes in suspension.

Authors:  H R Recalde
Journal:  J Immunol Methods       Date:  1984-04-13       Impact factor: 2.303

2.  Pulsatile flow and atherosclerosis in the human carotid bifurcation. Positive correlation between plaque location and low oscillating shear stress.

Authors:  D N Ku; D P Giddens; C K Zarins; S Glagov
Journal:  Arteriosclerosis       Date:  1985 May-Jun

3.  Subendothelial accumulation of unesterified cholesterol. An early event in atherosclerotic lesion development.

Authors:  H S Kruth
Journal:  Atherosclerosis       Date:  1985-11       Impact factor: 5.162

4.  Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid.

Authors:  D W Morel; J R Hessler; G M Chisolm
Journal:  J Lipid Res       Date:  1983-08       Impact factor: 5.922

5.  Uptake and degradation of human chylomicrons by macrophages in culture. Role of lipoprotein lipase.

Authors:  A M Ostlund-Lindqvist; S Gustafson; P Lindqvist; J L Witztum; J A Little
Journal:  Arteriosclerosis       Date:  1983 Sep-Oct

6.  Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease.

Authors:  R Tatami; H Mabuchi; K Ueda; R Ueda; T Haba; T Kametani; S Ito; J Koizumi; M Ohta; S Miyamoto; A Nakayama; H Kanaya; H Oiwake; A Genda; R Takeda
Journal:  Circulation       Date:  1981-12       Impact factor: 29.690

7.  Receptor-mediated uptake of remnant lipoproteins by cholesterol-loaded human monocyte-macrophages.

Authors:  B J Van Lenten; A M Fogelman; R L Jackson; S Shapiro; M E Haberland; P A Edwards
Journal:  J Biol Chem       Date:  1985-07-25       Impact factor: 5.157

8.  High resolution plasma lipoprotein cholesterol profiles by a rapid, high volume semi-automated method.

Authors:  B H Chung; J P Segrest; J T Cone; J Pfau; J C Geer; L A Duncan
Journal:  J Lipid Res       Date:  1981-08       Impact factor: 5.922

9.  Histochemical detection and differentiation of free and esterified cholesterol in swine atherosclerosis using filipin.

Authors:  H S Kruth; D L Fry
Journal:  Exp Mol Pathol       Date:  1984-06       Impact factor: 3.362

10.  A new protective factor in coronary artery disease. Very low density lipoprotein toxicity-preventing activity.

Authors:  B W Arbogast; L R Gill; H A Schwertner
Journal:  Atherosclerosis       Date:  1985-10       Impact factor: 5.162

View more
  10 in total

Review 1.  Postprandial lipemia and coronary risk.

Authors:  W Patsch; H Esterbauer; B Föger; J R Patsch
Journal:  Curr Atheroscler Rep       Date:  2000-05       Impact factor: 5.113

2.  Reducing Cholesterol Intake: Are the recommendations valid?

Authors:  J K Chan; B E McDonald
Journal:  Can Fam Physician       Date:  1991-03       Impact factor: 3.275

Review 3.  Triglycerides and heart disease: still a hypothesis?

Authors:  Ira J Goldberg; Robert H Eckel; Ruth McPherson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-04-28       Impact factor: 8.311

4.  Lipid abnormalities in rats given small doses of lead.

Authors:  A Skoczyńska; R Smolik; M Jeleń
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

5.  Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation.

Authors:  Limin Wang; Rajan Gill; Theresa L Pedersen; Laura J Higgins; John W Newman; John C Rutledge
Journal:  J Lipid Res       Date:  2008-09-23       Impact factor: 5.922

Review 6.  Triglyceride-rich lipoproteins and atherosclerosis.

Authors:  P Schwandt
Journal:  Drugs       Date:  1990       Impact factor: 9.546

7.  Lipoprotein lipase increases low density lipoprotein retention by subendothelial cell matrix.

Authors:  U Saxena; M G Klein; T M Vanni; I J Goldberg
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

8.  The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation.

Authors:  M I Mackness; C Abbott; S Arrol; P N Durrington
Journal:  Biochem J       Date:  1993-09-15       Impact factor: 3.857

9.  Potential role of the interaction between equine estrogens, low-density lipoprotein (LDL) and high-density lipoprotein (HDL) in the prevention of coronary heart and neurodegenerative diseases in postmenopausal women.

Authors:  Joel Perrella; Mauricio Berco; Anthony Cecutti; Alan Gerulath; Bhagu R Bhavnani
Journal:  Lipids Health Dis       Date:  2003-06-20       Impact factor: 3.876

Review 10.  Serum Triglycerides and Atherosclerotic Cardiovascular Disease: Insights from Clinical and Genetic Studies.

Authors:  Hayato Tada; Atsushi Nohara; Masa-Aki Kawashiri
Journal:  Nutrients       Date:  2018-11-17       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.